Notes / Company

Alivus Life Sciences Ltd.

ALIVUS BSE 543322 ISIN INE03Q201024 CDMO

Fundamentals

Market cap: ₹12,752 cr
P/E: 22.59×
ROE: 17.24%
Debt / equity: 0.00
Div yield: 0.48%
52-week range: 819.00 — 1148.40

Research on Tijori Finance

The timeline — 1 note on Alivus Life Sciences Ltd.

May 2026

21 May 26 · 15:23 IST Brief

Brief · Earnings

Alivus Life Sciences Q4 transcript adds colour, not surprise

The 83-page record of the May 15 concall confirms known numbers and elaborates on Dahej fire and CDMO timelines, but holds no incremental market-moving news.

Verify on exchange BSE filings for ALIVUS NSE filings for ALIVUS Tijori Finance company page